Biotech News

TherapeuticsMD Announces Third Quarter 2023 Financial Results

TherapeuticsMD (TXMD)TherapeuticsMD2026-06-25 13:46 ESTEarnings

Focus remains on cost control to maximize the value of our royalty assets Company announces evaluation of strategic alternatives BOCA RATON, Fla. --(BUSINESS WIRE)--Nov. 14, 2023-- TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical

Open original release

Related news

TXMDTherapeuticsMD2026-06-25 13:46 EST

TherapeuticsMD Announces First Quarter 2026 Financial Results

TXMDTherapeuticsMD2026-06-25 13:46 EST

TherapeuticsMD Announces Full Year 2023 Financial Results

TXMDTherapeuticsMD2026-06-25 13:46 EST

TherapeuticsMD Announces First Quarter 2024 Financial Results

TXMDTherapeuticsMD2026-06-25 13:46 EST

TherapeuticsMD Announces Second Quarter 2024 Financial Results

TXMDTherapeuticsMD2026-06-25 13:46 EST

TherapeuticsMD Announces Third Quarter 2024 Financial Results

TXMDTherapeuticsMD2026-06-25 13:46 EST

TherapeuticsMD Announces Full Year 2024 Financial Results

TXMDTherapeuticsMD2026-06-25 13:46 EST

TherapeuticsMD Announces First Quarter 2025 Financial Results

TXMDTherapeuticsMD2026-06-25 13:46 EST

TherapeuticsMD Announces Second Quarter 2025 Financial Results

TXMDTherapeuticsMD2026-06-25 13:46 EST

TherapeuticsMD Announces Third Quarter 2025 Financial Results

TXMDTherapeuticsMD2026-06-25 13:46 EST

TherapeuticsMD Announces Full Year 2025 Financial Results

View all latest news

TherapeuticsMD

TherapeuticsMD is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

Recent company news

TXMDTherapeuticsMD2026-06-26 10:45 EST

TherapeuticsMD Announces First Quarter 2026 Financial Results

TXMDTherapeuticsMD2026-06-26 10:45 EST

TherapeuticsMD Announces Third Quarter 2023 Financial Results

TXMDTherapeuticsMD2026-06-26 10:45 EST

TherapeuticsMD Announces Full Year 2023 Financial Results

TXMDTherapeuticsMD2026-06-26 10:45 EST

TherapeuticsMD Announces First Quarter 2024 Financial Results

TXMDTherapeuticsMD2026-06-26 10:45 EST

TherapeuticsMD Announces Second Quarter 2024 Financial Results

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States